Allianz Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-14,700
| Closed | -$501K | – | 1742 |
|
2024
Q1 | $501K | Hold |
14,700
| – | – | ﹤0.01% | 1429 |
|
2023
Q4 | $425K | Hold |
14,700
| – | – | ﹤0.01% | 1456 |
|
2023
Q3 | $405K | Hold |
14,700
| – | – | ﹤0.01% | 1498 |
|
2023
Q2 | $442K | Buy |
+14,700
| New | +$442K | ﹤0.01% | 1332 |
|
2019
Q2 | – | Sell |
-137,241
| Closed | -$4.81M | – | 2281 |
|
2019
Q1 | $4.81M | Buy |
137,241
+37,271
| +37% | +$1.31M | ﹤0.01% | 1260 |
|
2018
Q4 | $3.32M | Sell |
99,970
-98,052
| -50% | -$3.26M | ﹤0.01% | 1309 |
|
2018
Q3 | $9.97M | Buy |
198,022
+27,205
| +16% | +$1.37M | 0.01% | 1027 |
|
2018
Q2 | $10.2M | Sell |
170,817
-107,884
| -39% | -$6.46M | 0.01% | 967 |
|
2018
Q1 | $12.8M | Buy |
278,701
+104,829
| +60% | +$4.8M | 0.01% | 893 |
|
2017
Q4 | $6.93M | Buy |
173,872
+16,251
| +10% | +$648K | 0.01% | 1114 |
|
2017
Q3 | $6.31M | Sell |
157,621
-174,121
| -52% | -$6.97M | 0.01% | 1113 |
|
2017
Q2 | $14.3M | Sell |
331,742
-209,416
| -39% | -$9.02M | 0.01% | 855 |
|
2017
Q1 | $16.9M | Buy |
541,158
+18,858
| +4% | +$590K | 0.02% | 802 |
|
2016
Q4 | $13.2M | Sell |
522,300
-74,981
| -13% | -$1.89M | 0.01% | 905 |
|
2016
Q3 | $14.8M | Buy |
597,281
+221,857
| +59% | +$5.49M | 0.01% | 845 |
|
2016
Q2 | $7.65M | Sell |
375,424
-279,316
| -43% | -$5.69M | 0.01% | 1012 |
|
2016
Q1 | $9.99M | Sell |
654,740
-1,376
| -0.2% | -$21K | 0.01% | 913 |
|
2015
Q4 | $8.82M | Sell |
656,116
-29
| -0% | -$390 | 0.01% | 947 |
|
2015
Q3 | $9.21M | Buy |
656,145
+11,798
| +2% | +$166K | 0.01% | 897 |
|
2015
Q2 | $10.9M | Buy |
644,347
+418,485
| +185% | +$7.11M | 0.01% | 899 |
|
2015
Q1 | $2.73M | Buy |
225,862
+8,024
| +4% | +$97K | ﹤0.01% | 1175 |
|
2014
Q4 | $1.81M | Buy |
217,838
+12,561
| +6% | +$104K | ﹤0.01% | 1276 |
|
2014
Q3 | $1.78M | Sell |
205,277
-16,023
| -7% | -$139K | ﹤0.01% | 1247 |
|
2014
Q2 | $2.42M | Buy |
+221,300
| New | +$2.42M | ﹤0.01% | 1121 |
|